scholarly journals Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group.

1996 ◽  
Vol 80 (11) ◽  
pp. 969-972 ◽  
Author(s):  
K R Wilhelmus ◽  
C R Dawson ◽  
B A Barron ◽  
P Bacchetti ◽  
L Gee ◽  
...  
Keyword(s):  
Risk Factors ◽  
Herpes Simplex Virus ◽  
Herpes Simplex ◽  
Eye Disease ◽  
Study Group ◽  
Stromal Keratitis ◽  
Disease Study ◽  
Simplex Virus

scholarly journals Identification and Characterization of Herpes Simplex Virus‐Specific CD4+T Cells in Corneas of Herpetic Stromal Keratitis Patients

1998 ◽  
Vol 177 (2) ◽  
pp. 484-488 ◽  
Author(s):  
Georges M. G. M. Verjans ◽  
Lies Remeijer ◽  
Robert S. van Binnendijk ◽  
José G. C. Cornelissen ◽  
Hennie J. Völker‐Dieben ◽  
...  
Keyword(s):  
T Cells ◽  
Herpes Simplex Virus ◽  
Herpes Simplex ◽  
Cd4 T Cells ◽  
Herpetic Stromal Keratitis ◽  
Stromal Keratitis ◽  
Simplex Virus ◽  
Identification And Characterization

scholarly journals An Assessment of Risk Factors for Herpes Simplex Virus Type 2 Infection in Malawian Women Using 2 Classifications for the HerpeSelect 2 Test

2020 ◽  
Vol 47 (3) ◽  
pp. 192-196
Author(s):  
Payal Chakraborty ◽  
Alison H. Norris ◽  
Sarah Huber-Krum ◽  
Sarah Garver ◽  
Robert B. Hood ◽  
...  
Keyword(s):  
Risk Factors ◽  
Herpes Simplex Virus ◽  
Herpes Simplex ◽  
Virus Type ◽  
Herpes Simplex Virus Type ◽  
Simplex Virus

Topical Corticosteroids for Herpes Simplex Stromal Keratitis

2020 ◽  
pp. 9-14
Author(s):  
Alan D. Penman ◽  
Kimberly W. Crowder ◽  
William M. Watkins
Keyword(s):  
Herpes Simplex ◽  
Acute Treatment ◽  
Visual Outcome ◽  
Eye Disease ◽  
Controlled Clinical Trial ◽  
Study Enrollment ◽  
Topical Corticosteroids ◽  
Stromal Keratitis ◽  
Disease Study ◽  
Therapy Treatment

The Herpetic Eye Disease Study (HEDS) was a randomized, double-masked, placebo-controlled, clinical trial to determine the efficacy of topical corticosteroids as adjunctive therapy in the treatment of herpes simplex stromal keratitis in patients who had not received any corticosteroids for at least 10 days before study enrollment. The study showed that topical corticosteroids can be used judiciously with protective antiviral cover in the acute treatment of patients with herpes simplex stromal keratitis who have not recently received corticosteroid therapy. Treatment reduced persistence or progression of stromal inflammation and shortened the duration of herpes simplex stromal keratitis. Postponing steroids during careful observation for a few weeks delayed resolution of stromal keratitis but did not worsen visual outcome at 6 months.

Sign in / Sign up

Export Citation Format

Share Document